|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1996-7-9
|
|
pubmed:abstractText |
The aim of the study was to compare high-versus low-dose cisplatin in combination with cyclophosphamide and epidoxorubicin as primary chemotherapy for suboptimal stage III and IV ovarian cancer.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
pubmed-author:AlgeriRR,
pubmed-author:BelliniAA,
pubmed-author:BoccardiLL,
pubmed-author:BrunetteMM,
pubmed-author:BruzzoneMM,
pubmed-author:CarninoFF,
pubmed-author:CatsafadosEE,
pubmed-author:ChiariKK,
pubmed-author:FogliaGG,
pubmed-author:GadducciAA,
pubmed-author:GalliVV,
pubmed-author:IskraLL,
pubmed-author:MammolitiSS,
pubmed-author:ParodiGG,
pubmed-author:RagniNN,
pubmed-author:RossiLL,
pubmed-author:RubagottiAA,
pubmed-author:RugiatiSS,
pubmed-author:YonemitsuHH
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
14
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
351-6
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:8636743-Adult,
pubmed-meshheading:8636743-Aged,
pubmed-meshheading:8636743-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:8636743-Cisplatin,
pubmed-meshheading:8636743-Cyclophosphamide,
pubmed-meshheading:8636743-Drug Administration Schedule,
pubmed-meshheading:8636743-Epirubicin,
pubmed-meshheading:8636743-Female,
pubmed-meshheading:8636743-Humans,
pubmed-meshheading:8636743-Middle Aged,
pubmed-meshheading:8636743-Neoplasm, Residual,
pubmed-meshheading:8636743-Ovarian Neoplasms,
pubmed-meshheading:8636743-Survival Rate,
pubmed-meshheading:8636743-Treatment Outcome
|
|
pubmed:year |
1996
|
|
pubmed:articleTitle |
High-dose versus low-dose cisplatin in combination with cyclophosphamide and epidoxorubicin in suboptimal ovarian cancer: a randomized study of the Gruppo Oncologico Nord-Ovest.
|
|
pubmed:affiliation |
Gruppo Oncologico Nord-Ovest, Pisa, Italy.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
